miR-145 also appears to target several genes involved in PCa progression, including c-Myc, a transcription factor that regulates cell growth and differentiation, and MUC1, a transmembrane protein that promotes cell survival and invasiveness. The gene discussed is MYC; the disease is posterior cortical atrophy.